[U.S. Food and Drug Administration]

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policymakers with persons outside the executive branch of the Federal Government.

Week of January 2 - 8, 1998

FDA Official and Title Date and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Sharon Smith Holston, Deputy Commissioner for External Affairs 1/8 Bethesda, MD FDA Officials Various organizations Public Workshop: Minimizing Medical Product Errors- A systems Approach
Fred R. Shank, Ph.D., Director, CFSAN 12/15 FB-08 John Vanderveen, Carl Reynolds, John Kvenberg, LeeAnne Jackson, Larry Edwards Bryant Silberman, Produce Mktg. Assoc.; Roger Askey, Bob Evans Restaurant New Food Safety Advisory Council
Fred R. Shank, Ph.D., Director, CFSAN 12/16 FB-08 Alan Rulis, Patricia Hansen, Catherine Bailey Newton Williams, Anthony Shaw, Hoechst Corp.; Jon Simplico, Nutrinova; Stuart Pape, Patton, Boggs Acesulfame-K.
Fred R. Shank, Ph.D., Director, CFSAN 12/16 FB-08 Elizabeth Campbell, Felicia Satchell, John Gordon Bruce Stillings, Carol Knight, Chocolate Manufacturer's Association Petitions update
Fred R. Shank, Ph.D., Director, CFSAN 12/17 FB-08 Janice Oliver, LeeAnne Jackson Stacy Zaawel, John Aquirre, United Fresh Fruit & Vegetable Assoc. Guidance Document
Marlene E. Haffner, Director, Office of Orphan Products Development 1/14 Rockville, MD John McCormick, M.D., Dep. Dir., OPD., Erica McNeilly, R.Ph., Reviewing Pharmacist Peter Vacarri, R.Ph., Assoc. Dir. Reg. Afrs., Mr. Eric Gervais, Exec. VP., Mr. Alain Paris, Financial Advisor, CATO Research; Mrs. Carole Leduc, Duchesnay, Inc., Med. Info. Director Discussion of designation
Dr. Stephen F. Sundlof, Director, CVM 1/5 Rockville, MD Several CVM staff Nancy Cook, Ken Johannes, Gerald May, Pet Food Inst. Pet Food Export Certification
Dr. Stephen F. Sundlof, Director, CVM 1/7 Wash., D.C. none Reps. From the Animal Health Inst. Update on AHI activity
Kathryn C. Zoon, Ph.D., Director, CBER 1/5 San Francsico, CA none CA Separation Science Society attendees 2nd Symposium on the Analysis of Well-Characterized Biotechnology Pharmaceuticals: FDA Regulation of Well-Characterized Products
Kathryn C. Zoon, Ph.D., Director, CBER 1/6 Charleston, SC none Defense Advanced Research Projects Agency Principal Investigation Conference Regulation of Biotech Products
Mark A. Elengold, Deputy Director for Operations, CBER 1/6 Bethesda, MD other CBER staff North American Vaccine Licensing Staff Pending application
Mark A. Elengold, Deputy Director for Operations, CBER 1/7 Rockville,, MD other FDA staff North American Vaccine Licensing Staff; Nancy Buc, Buc & Beardsley; Milo Hilty, Abbott Labs. Pending application

Return to FDA News Page

January 12, 1998